Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Status
Recruiting
Trial Recruitment Size
120
Trial Sponsor
Trial Collaborator
Clinical Trial Start Date
April 3, 2020
Primary Completion Date
July 1, 2021
Study Completion Date
July 1, 2021
Clinical Trial Study Type
Interventional
Interventional Trial Purpose
Prevention0
Intervention Type
Drug0
Device0
Biological
Intervention Name
CELLECTRA® 20000
INO-48000
Interventional Trial Phase
Phase 1
Participating Facility
Official Name
Phase 1 Open-label Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4800, a Prophylactic Vaccine Against SARS-CoV-2, Administered Intradermally Followed by Electroporation in Healthy Volunteers0
Last Updated
April 15, 2022
0Allocation Type
Non-Randomized0
Intervention Model
Sequential Assignment0
Masking Type
None (Open Label)0
No article content yet.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
